Pricing Log in Create free account

SeaStar Medical Holding Corporation (ICU) vs IN8bio, Inc. (INAB)

SeaStar Medical Holding Corporation and IN8bio, Inc. are both Biotechnology companies. SeaStar Medical Holding Corporation is the larger, with a market value of $10.2M against $8.2M — 1.2× the size. IN8bio, Inc. has the higher net margin (0.00% vs −795.5%) and the lower return on invested capital (−2,948.6% vs 0.00%). Across the 13 metrics below, IN8bio, Inc. leads on 8 and SeaStar Medical Holding Corporation on 5.

Valuation

Metric ICU INAB Biotechnology median
P/E n/m n/m 10.26
P/S 4.53 n/m 9.18
P/B 1.81 0.89 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.08 0.65
EV/Sales 1.96 n/m 8.98
Earnings yield (205.79%) (255.95%) (34.89%)
Free cash flow yield (176.47%) (89.47%) (24.52%)

Profitability

Metric ICU INAB Biotechnology median
Gross margin 92.64% 0.00% 65.16%
Operating margin (816.75%) 0.00% 0.00%
Net margin (795.50%) 0.00% 0.00%
Free cash flow margin (799.36%) 0.00% 0.00%
Return on equity (356.87%) (111.11%) (50.12%)
Return on assets (160.02%) (90.80%) (45.60%)
Return on invested capital 0.00% (2,948.56%) 0.00%

Growth

Metric ICU INAB Biotechnology median
Revenue growth (TTM) 123.63% — 6.26%
EPS growth (last fiscal year) 91.16% 74.06% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ICU INAB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.89 8.21 4.89
Net debt to EBITDA 0.99 1.56 1.01

Dividend

Metric ICU INAB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ICU INAB Biotechnology median
Market cap 10.20m 8.19m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack